Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Down 5.6% in April

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 3,520,000 shares, a decline of 5.6% from the March 31st total of 3,730,000 shares. Approximately 3.9% of the shares of the stock are sold short. Based on an average daily volume of 566,600 shares, the days-to-cover ratio is presently 6.2 days.

Analysts Set New Price Targets

ACHC has been the topic of several research reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Monday, March 4th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price target for the company in a research report on Thursday, April 25th. Stephens upgraded Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target for the company in a research report on Friday, January 5th. Mizuho lifted their price target on Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 6th. Finally, UBS Group lifted their price target on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Four research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $92.00.

Insider Transactions at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the sale, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Avidity Partners Management LP grew its stake in Acadia Healthcare by 61.8% in the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock worth $89,944,000 after purchasing an additional 441,692 shares in the last quarter. Sea Cliff Partners Management LP bought a new position in Acadia Healthcare in the fourth quarter worth approximately $26,338,000. Vaughan Nelson Investment Management L.P. bought a new position in Acadia Healthcare in the fourth quarter worth approximately $24,157,000. OFI Invest Asset Management grew its stake in Acadia Healthcare by 290.5% in the third quarter. OFI Invest Asset Management now owns 331,129 shares of the company’s stock worth $21,990,000 after purchasing an additional 246,322 shares in the last quarter. Finally, Jennison Associates LLC grew its stake in Acadia Healthcare by 26.1% in the fourth quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock worth $89,327,000 after purchasing an additional 238,114 shares in the last quarter.

Acadia Healthcare Stock Down 0.9 %

Shares of NASDAQ:ACHC opened at $73.94 on Wednesday. Acadia Healthcare has a 1 year low of $66.49 and a 1 year high of $87.77. The business has a 50 day simple moving average of $77.91 and a two-hundred day simple moving average of $77.73. The firm has a market capitalization of $6.83 billion, a PE ratio of -295.75, a price-to-earnings-growth ratio of 2.17 and a beta of 1.31. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The business had revenue of $742.80 million during the quarter, compared to analyst estimates of $727.60 million. During the same quarter in the previous year, the business earned $0.70 earnings per share. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. On average, equities analysts predict that Acadia Healthcare will post 3.57 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.